Travere Therapeutics, Inc. (TVTX): Net Income
-$25.55M
Year ended 2025-12-31
-$43.46M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$25.55M | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$321.55M | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$111.40M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$278.48M | n/m | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | -$180.09M | n/m | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | -$169.43M | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$146.43M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$102.68M | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$59.73M | n/m | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | -$47.90M | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $117.24M | n/m | 2018-07-06, From 2015-01-01 |
| 2014-12-31 | -$110.94M | n/m | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | -$34.62M | n/m | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | -$30.34M | n/a | 2015-07-09, From 2012-01-01 |
| 2012-02-29 | -$14.8K | n/m | 2012-05-24, From 2011-03-02 |
| 2011-02-28 | -$23.0K | n/a | 2012-05-24, From 2010-03-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | -$25.55M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $20.45M | +159.1% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$732.94M | n/m |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | -$23.36M | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$175.54M | n/m |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $456.91M | n/m |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $37.03M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $271.17M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$61.60M | n/m |
Compare TVTX, NATR, BBIO, MIRM side by side · Screen every company in Pharmaceutical Preparations ↗